Literature DB >> 32997097

From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer.

Naomi R Wray1,2, Tian Lin1, Jehannine Austin3,4, John J McGrath2,5,6, Ian B Hickie7,8, Graham K Murray1,8,9, Peter M Visscher1.   

Abstract

Importance: Polygenic risk scores (PRS) are predictors of the genetic susceptibilities of individuals to diseases. All individuals have DNA risk variants for all common diseases, but genetic susceptibility differences between people reflect the cumulative burden of these. Polygenic risk scores for an individual are calculated as weighted counts of thousands of risk variants that they carry, where the risk variants and their weights have been identified in genome-wide association studies. Here, we review the underlying basic science of PRS, providing a foundation for understanding the potential clinical utility and limitations of PRS. Observations: Polygenic risk scores can be calculated for a wide range of diseases from a saliva or blood sample using genotyping technologies that are inexpensive. While genotyping only needs to be done once for each individual in their lifetime, the PRS can be recalculated as identification of risk variants improves. On their own, PRS will never be able to establish or definitively predict future diagnoses of common complex conditions because genetic factors only contribute part of the risk, and PRS will only ever capture part of the genetic contributions. Nonetheless, just as clinical medicine uses a multitude of other predictive measures, PRS either on their own or as part of multivariable predictive algorithms could play a role. Conclusions and Relevance: Utility of PRS in clinical medicine and ethical issues related to their use should be evaluated in the context of realistic expectations of what PRS can and cannot deliver. For different diseases, PRS could have utility in community settings (stratification to better triage people into established screening programs) or could contribute to clinical decision-making for those presenting with symptoms but where formal diagnosis is unclear. In principle, PRS could contribute to treatment choices, but more data are needed to allow development of PRS in this context.

Entities:  

Mesh:

Year:  2021        PMID: 32997097     DOI: 10.1001/jamapsychiatry.2020.3049

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  43 in total

1.  Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review.

Authors:  Elena Dragioti; Joaquim Radua; Marco Solmi; Celso Arango; Dominic Oliver; Samuele Cortese; Peter B Jones; Jae Il Shin; Christoph U Correll; Paolo Fusar-Poli
Journal:  Mol Psychiatry       Date:  2022-04-28       Impact factor: 15.992

2.  Evaluating risk for alcohol use disorder: Polygenic risk scores and family history.

Authors:  Dongbing Lai; Emma C Johnson; Sarah Colbert; Gayathri Pandey; Grace Chan; Lance Bauer; Meredith W Francis; Victor Hesselbrock; Chella Kamarajan; John Kramer; Weipeng Kuang; Sally Kuo; Samuel Kuperman; Yunlong Liu; Vivia McCutcheon; Zhiping Pang; Martin H Plawecki; Marc Schuckit; Jay Tischfield; Leah Wetherill; Yong Zang; Howard J Edenberg; Bernice Porjesz; Arpana Agrawal; Tatiana Foroud
Journal:  Alcohol Clin Exp Res       Date:  2022-03-10       Impact factor: 3.455

3.  Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences.

Authors:  Stacey Pereira; Katrina A Muñoz; Brent J Small; Takahiro Soda; Laura N Torgerson; Clarissa E Sanchez; Jehannine Austin; Eric A Storch; Gabriel Lázaro-Muñoz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2022-07-06       Impact factor: 3.358

Review 4.  Dissecting polygenic signals from genome-wide association studies on human behaviour.

Authors:  Abdel Abdellaoui; Karin J H Verweij
Journal:  Nat Hum Behav       Date:  2021-05-13

Review 5.  Twin studies to GWAS: there and back again.

Authors:  Naomi P Friedman; Marie T Banich; Matthew C Keller
Journal:  Trends Cogn Sci       Date:  2021-07-24       Impact factor: 24.482

Review 6.  Genetics of eating disorders in the genome-wide era.

Authors:  Hunna J Watson; Alish B Palmos; Avina Hunjan; Jessica H Baker; Zeynep Yilmaz; Helena L Davies
Journal:  Psychol Med       Date:  2021-02-15       Impact factor: 10.592

7.  Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample.

Authors:  Humberto Nicolini; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Beatriz Camarena; Clara Fleiz Bautista; Marycarmen Bustos-Gamiño; Alejandro Aguilar García; Nuria Lanzagorta; María Elena Medina-Mora
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

8.  A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts.

Authors:  Guiyan Ni; Jian Zeng; Joana A Revez; Ying Wang; Zhili Zheng; Tian Ge; Restuadi Restuadi; Jacqueline Kiewa; Dale R Nyholt; Jonathan R I Coleman; Jordan W Smoller; Jian Yang; Peter M Visscher; Naomi R Wray
Journal:  Biol Psychiatry       Date:  2021-05-04       Impact factor: 12.810

Review 9.  Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force.

Authors:  Ralph Kupka; Anne Duffy; Jan Scott; Jorge Almeida; Vicent Balanzá-Martínez; Boris Birmaher; David J Bond; Elisa Brietzke; Ines Chendo; Benicio N Frey; Iria Grande; Danella Hafeman; Tomas Hajek; Manon Hillegers; Marcia Kauer-Sant'Anna; Rodrigo B Mansur; Afra van der Markt; Robert Post; Mauricio Tohen; Hailey Tremain; Gustavo Vazquez; Eduard Vieta; Lakshmi N Yatham; Michael Berk; Martin Alda; Flávio Kapczinski
Journal:  Bipolar Disord       Date:  2021-07-23       Impact factor: 5.345

10.  The Identifying Depression Early in Adolescence Risk Stratified Cohort (IDEA-RiSCo): Rationale, Methods, and Baseline Characteristics.

Authors:  Christian Kieling; Claudia Buchweitz; Arthur Caye; Pedro Manfro; Rivka Pereira; Anna Viduani; Maurício Anés; Lucas Battel; Silvia Benetti; Helen L Fisher; Rakesh Karmacharya; Brandon A Kohrt; Thais Martini; Sandra Petresco; Jader Piccin; Thiago Rocha; Luis Augusto Rohde; Fernanda Rohrsetzer; Laila Souza; Bruna Velazquez; Annabel Walsh; Leehyun Yoon; Zuzanna Zajkowska; Valentina Zonca; Johnna R Swartz; Valeria Mondelli
Journal:  Front Psychiatry       Date:  2021-06-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.